Increased urinary excretion of nephrin, podocalyxin, and βig-h3 in women with preeclampsia.
Emerging evidence has shown that podocyte injury and reduced specific podocyte protein expressions contribute to proteinuria in preeclampsia. We collected urine specimens from women with preeclampsia to study whether podocyte-specific protein shedding is associated with renal barrier dysfunction. Urine specimens from women with normal pregnancies and from pregnant women complicated by chronic hypertension were used for comparison. We determined soluble podocyte slit protein nephrin levels in the urine specimens. Podocalyxin, βig-h3, and VEGF concentrations were also measured. We found that nephrin and podocalyxin were barely detectable in the urine specimens from normal pregnant women and from women with chronic hypertension. In preeclampsia, urinary nephrin and podocalyxin concentrations were significantly increased and highly correlated to each other, r(2) = 0.595. Nephrin and podocalyxin were also correlated with urine protein concentrations. βig-h3 was detected in the urine specimens from women with preeclampsia, and it is highly correlated with nephrin and podocalyxin concentrations in preeclampsia. βig-h3 was undetectable in normal pregnancy and pregnancy complicated by chronic hypertension. Elevated VEGF levels were also found in women with preeclampsia compared with those of normal pregnancy and pregnancy complicated by chronic hypertension. These results provide strong evidence that podocyte protein shedding occurs in preeclampsia, and their levels are associated with proteinuria. The finding of urinary βig-h3 excretion in preeclampsia suggests that increased transforming growth factor activity might also be involved in the kidney lesion in this pregnancy disorder.
Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA. ywang1@lsuhsc.edu
Yuping
Y
Wang
Shuang
S
Zhao
Susan
S
Loyd
Lynn J
LJ
Groome
D000328:Adult; D015415:Biomarkers / Q000652:urine; D016022:Case-Control Studies; D016326:Extracellular Matrix Proteins / Q000652:urine*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000652:urine; D007668:Kidney / Q000378:metabolism; D008565:Membrane Proteins / Q000652:urine*; D011225:Pre-Eclampsia / Q000652:urine*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000652:urine*; D012795:Sialoglycoproteins / Q000652:urine*; D015398:Signal Transduction / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000652:urine*; D042461:Vascular Endothelial Growth Factor A / Q000652:urine; D000099222:betaIG-H3 Protein
D015415:Biomarkers; D016326:Extracellular Matrix Proteins; D008565:Membrane Proteins; D012795:Sialoglycoproteins; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A; D000099222:betaIG-H3 Protein; C113267:nephrin; C001643:podocalyxin